Ivarsson joins Moderna as it drives its hefty pipeline forward. One would think that with 21 programs, Moderna has its hands full. But it looks like the mRNA biotech is planning to build out its pipeline even more.https://www.fiercebiotech.com/biotech/ex-shire-takeda-clinical-trials-chief-melanie-ivarsson-lands-at-moderna …
0 replies
1 proslijeđeni tweet
1 korisnik označava da mu se sviđa
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.